53.81
-2.04(-3.65%)
Currency In USD
Address
400 Spectrum Center Drive
Irvine, DE
United States of America
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
113
First IPO Date
N/A
| Name | Title | Pay | Year Born |
| Arthur Kuan | Chairman & Chief Executive Officer | 1.04M | 1991 |
| Vijay Kasturi | Chief Medical Officer | 299,688 | 1968 |
| Ambaw Bellete | President & Chief Operating Officer | 769,967 | 1971 |
| Bing Kung | Vice President of Corporate Development | 0 | N/A |
| James DeTore | Interim Principal Financial & Accounting Officer | 0 | 1965 |
| Robert Lapetina | Interim Principal Financial & Accounting Officer | 0 | 1975 |
| Joshua F. Patterson | General Counsel, Chief Compliance Officer & Secretary | 0 | 1976 |
| Swapnil Bhargava | Chief Technical Officer | 0 | N/A |
| Amy Steele | Vice President of Finance & Administration | 0 | N/A |
| Sarah Connors | Vice President of Communications & Patient Advocacy | 0 | N/A |
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
